MONOPAR THERAPEUTICS INC
MNPRNASDAQ🏆 #2474 by market capEarnings Aug 12US Equity
$114.24▼ $0.22 (−0.19%)
Live1h▲ 1.4%
24h▼ 0.2%
7d▼ 4.5%
14d▲ 6.0%
30d▲ 11.3%
1y▲ 263.8%
🏦Market Cap
$765M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
42
Weak
📊
Analyst Ratings
Price
$114.24
Total
13
Raised
1
Lowered
3
Avg PT
$118.00
H / L
$125 / $105
| Institution | Action | Rating | Date |
|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2026-07-22 |
BTIG | Reiterated | Buy | 2026-06-30 |
Chardan Capital | Reiterated | Buy | 2026-03-30 |
Raymond James | Downgraded | Strong Buy → Outperform | 2025-11-14 |
Oppenheimer | Reiterated | Outperform | 2025-10-02 |
Piper Sandler | Reiterated | Overweight | 2025-09-25 |
Cantor Fitzgerald | Reiterated | Overweight | 2025-08-27 |
Jones Trading | Downgraded | Buy → Hold | 2025-04-02 |
JonesTrading | Upgraded | Hold → Buy | 2024-04-11 |
Maxim Group | Downgraded | Buy → Hold | 2023-03-29 |
EF Hutton | Reiterated | Buy | 2023-03-28 |
Roth Capital | Reiterated | Buy | 2021-01-28 |
Brookline Capital | Reiterated | Buy | 2020-02-19 |
One row per institution, most recent rating